Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
Conditions
Migraine Disorders
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Pharmacovigilance Department, Osaka, Japan
Contact: Study coordinator (Satoshi Komaniwa, PhD)
Study leads
Yasuhiko Fukuta, PhD
Study Director
Otsuka Pharmaceutical Co., Ltd.